Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
There is a lack of understanding whether plasma levels of anticancer drugs (such as pazopanib) correlate with intra-tumoral levels and whether the plasma compartment is the best surrogate for pharmacokinetic and pharmacodynamic evaluation. Therefore, we aimed to quantify pazopanib concentrations in...
Saved in:
Main Authors: | Laura Molenaar-Kuijsten, Milan van Meekeren, Remy B. Verheijen, Judith V. M. G. Bovée, Marta Fiocco, Bas Thijssen, Hilde Rosing, Alwin D. R. Huitema, Aisha B. Miah, Hans Gelderblom, Rick L. M. Haas, Neeltje Steeghs |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c3f1d4b3365f4a8dad8a15b3f5a71773 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
by: Eijiro Shimada, et al.
Published: (2021) -
Prolonged Survival Using First-Line Pazopanib in a Filipino Male with Renal Cell Carcinoma and Brain Metastasis: A Case Report
by: Christianne V. Mojica, et al.
Published: (2021) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
by: Sewanti Limaye, et al.
Published: (2021) -
Clinical Experience with Apatinib and Camrelizumab in Advance Clear Cell Sarcoma: A Retrospective Study
by: Wang J, et al.
Published: (2021) -
Insuficiencia cardíaca como presentación de sarcoma cardíaco. Caso clínico y revisión de la literatura
by: Cañete,Iván, et al.
Published: (2021)